Display options
Cite
Hahl J, Simell TT, Simell OG, et al. Costs of insulin-dependent diabetes mellitus. Pharmacoeconomics. 1996;9(1):24-38doi: 10.2165/00019053-199609010-00004.
Hahl, J., Simell, T. T., Simell, O. G., & Sintonen, H. (1996). Costs of insulin-dependent diabetes mellitus. PharmacoEconomics, 9(1), 24-38. https://doi.org/10.2165/00019053-199609010-00004
Hahl, J, et al. "Costs of insulin-dependent diabetes mellitus." PharmacoEconomics vol. 9,1 (1996): 24-38. doi: https://doi.org/10.2165/00019053-199609010-00004
Hahl J, Simell TT, Simell OG, Sintonen H. Costs of insulin-dependent diabetes mellitus. Pharmacoeconomics. 1996 Jan;9(1):24-38. doi: 10.2165/00019053-199609010-00004. PMID: 10160085.
Copy Download .nbib Format: NLM
Share it on

Pharmacoeconomics. 1996 Jan;9(1):24-38. doi: 10.2165/00019053-199609010-00004.

Costs of insulin-dependent diabetes mellitus.

PharmacoEconomics

J Hahl, T T Simell, O G Simell, H Sintonen

Affiliations

  1. Department of Paediatrics, University of Turku, Finland.

PMID: 10160085 DOI: 10.2165/00019053-199609010-00004

Abstract

Insulin-dependent diabetes mellitus (IDDM) is a prevalent chronic disease that causes marked personal and financial costs for patients, their families and society. Accurate information on costs of the disease is scarce. In this article, we review studies on disease and disease stage-connected costs at the individual and societal levels, and discuss possibilities of decreasing or preventing costs attributable to IDDM. The 3 disease stages are the initial treatment, follow-up after the initial treatment and late treatment. Total costs of IDDM in a given country depend on the incidence of the disease and the efficiency (cost effectiveness) of treatment. Besides everyday treatment costs, the acute and long term complications of the disease cause major additional costs. The lifetime financial costs of IDDM and the amount of human suffering are always substantial. The costs of the 3 clinical stages of IDDM differ markedly. The initial and late periods induce cost peaks, but the costs of follow-up after initial treatment are small. During initial treatment, costs depend mostly on the possible length of hospitalisation. During the late treatment period, costs begin to accumulate rapidly because of long term complications such as diabetic nephropathy, retinopathy, neuropathy and macrovascular disease. Intensive ambulatory care, effective patient education that results in normoglycaemia or near-normoglycaemia in patients and, if needed, shortening of hospitalisations, are the only means to restrict or decrease the costs of IDDM until primary prevention is available. Postponing complications by any length of time will always decrease human suffering and lead to marked savings in healthcare resources.

Cited by

References

  1. Diabet Med. 1993 Nov;10(9):855-62 - PubMed
  2. Lancet. 1992 Apr 11;339(8798):905-9 - PubMed
  3. Diabetologia. 1991 Mar;34(3):164-70 - PubMed
  4. Surg Gynecol Obstet. 1992 Aug;175(2):135-40 - PubMed
  5. Diabetologia. 1992 Mar;35(3):267-71 - PubMed
  6. Am J Public Health. 1985 Nov;75(11):1325-6 - PubMed
  7. Diabetes Care. 1992 Jan;15(1):66-74 - PubMed
  8. Can J Public Health. 1989 Mar-Apr;80(2):124-8 - PubMed
  9. Diabet Med. 1994 Mar;11(2):166-9 - PubMed
  10. N Engl J Med. 1993 Jul 29;329(5):304-9 - PubMed
  11. Pediatr Clin North Am. 1984 Jun;31(3):545-67 - PubMed
  12. Diabetes Care. 1994 Nov;17(11):1257-63 - PubMed
  13. Diabetes Care. 1989 Jan;12(1):24-31 - PubMed
  14. Ophthalmology. 1989 Feb;96(2):255-64 - PubMed
  15. Diabetologia. 1995 Feb;38(2):236-43 - PubMed
  16. Diabetologia. 1994 Mar;37(3):278-85 - PubMed
  17. J Pediatr. 1986 Apr;108(4):491-7 - PubMed
  18. Am J Med. 1991 Apr;90(4):450-9 - PubMed
  19. Pediatrics. 1991 Dec;88(6):1187-93 - PubMed
  20. Diabetes Care. 1985 Sep-Oct;8 Suppl 1:94-100 - PubMed
  21. Diabete Metab. 1989;15(5 Pt 2):327-32 - PubMed
  22. Ophthalmology. 1991 Oct;98(10):1565-73; discussion 1574 - PubMed
  23. J Intern Med. 1993 Apr;233(4):321-6 - PubMed
  24. J Diabetes Complications. 1993 Jan-Mar;7(1):15-27 - PubMed
  25. Can Med Assoc J. 1976 May 8;114(9):780-3 - PubMed
  26. Lancet. 1983 May 28;1(8335):1175-9 - PubMed
  27. Nephron. 1985;40(2):129-38 - PubMed
  28. Diabet Med. 1987 May-Jun;4(3):201-10 - PubMed
  29. MMWR CDC Surveill Summ. 1993 Jun 4;42(2):1-20 - PubMed
  30. Diabetes Care. 1986 Jan-Feb;9(1):81-6 - PubMed
  31. Am J Epidemiol. 1991 Jan;133(1):67-72 - PubMed
  32. N Engl J Med. 1987 Nov 26;317(22):1390-8 - PubMed
  33. J Enterostomal Ther. 1989 Nov-Dec;16(6):247-55 - PubMed
  34. Diabetes. 1986 Dec;35(12):1332-9 - PubMed
  35. Diabetes Care. 1990 May;13(5):492-8 - PubMed
  36. Diabetes Care. 1994 Aug;17(8):909-17 - PubMed
  37. Med J Aust. 1987 Jan 5;146(1):19-22 - PubMed
  38. N Engl J Med. 1992 Mar 5;326(10):673-7 - PubMed
  39. JAMA. 1988 Jul 1;260(1):37-41 - PubMed
  40. Clin Endocrinol Metab. 1986 Nov;15(4):783-805 - PubMed
  41. Lancet. 1993 Apr 10;341(8850):927-8 - PubMed
  42. Acta Endocrinol Suppl (Copenh). 1980;238:103-8 - PubMed
  43. Diabetologia. 1993 Dec;36(12):1309-14 - PubMed
  44. Diabetologia. 1988 Jun;31(6):351-4 - PubMed
  45. Diabetologia. 1991 May;34(5):362-5 - PubMed
  46. Diabetes Care. 1992 Jul;15(7):915-7 - PubMed
  47. Diabetes Res Clin Pract. 1989 Nov 6;7(4):271-6 - PubMed
  48. Pediatr Clin North Am. 1984 Jun;31(3):611-21 - PubMed
  49. Diabetes Care. 1988 Nov-Dec;11(10):833-9 - PubMed
  50. Acta Med Scand Suppl. 1983;671:19-27 - PubMed
  51. Diabetes Care. 1984 Jul-Aug;7(4):367-71 - PubMed
  52. Med J Aust. 1990 Feb 5;152(3):115-7 - PubMed
  53. Diabetologia. 1992 Jan;35(1):70-6 - PubMed
  54. Dan Med Bull. 1990 Dec;37(6):530-46 - PubMed
  55. Lancet. 1991 Mar 16;337(8742):656-60 - PubMed
  56. Arch Ophthalmol. 1984 Apr;102(4):527-32 - PubMed
  57. Diabetes. 1994 Feb;43(2):313-7 - PubMed
  58. BMJ. 1993 Jun 26;306(6894):1722-5 - PubMed
  59. Diabetes Care. 1985 Jul-Aug;8(4):391-406 - PubMed
  60. Diabetes Care. 1995 Oct;18(10):1383-94 - PubMed
  61. Arch Intern Med. 1990 Jan;150(1):31-43 - PubMed
  62. Diabetologia. 1993 Oct;36(10):961-5 - PubMed
  63. Diabetes Care. 1985 May-Jun;8(3):268-73 - PubMed
  64. Diabetes Care. 1995 Jun;18(6):761-5 - PubMed
  65. Diabetes Care. 1992 Aug;15(8):997-1001 - PubMed
  66. Diabetologia. 1993 Dec;36(12):1293-8 - PubMed
  67. Diabetes Care. 1992 Oct;15(10):1369-77 - PubMed
  68. Am J Public Health. 1987 Dec;77(12):1549-50 - PubMed
  69. N Engl J Med. 1988 Jan 28;318(4):223-9 - PubMed
  70. Diabetes Care. 1994 Jul;17(7):697-703 - PubMed
  71. N Engl J Med. 1986 Feb 13;314(7):403-8 - PubMed
  72. N Engl J Med. 1993 Sep 30;329(14 ):977-86 - PubMed
  73. Diabetes. 1988 Aug;37(8):1113-9 - PubMed
  74. Diabet Med. 1991 Jun;8(5):469-74 - PubMed
  75. BMJ. 1992 Jan 4;304(6818):19-22 - PubMed
  76. Diabetologia. 1992 Dec;35 Suppl 2:A9-11 - PubMed
  77. Diabetologia. 1991 May;34(5):370-2 - PubMed
  78. Am J Dis Child. 1983 Aug;137(8):782-6 - PubMed
  79. J Intern Med. 1994 May;235(5):463-71 - PubMed
  80. Diabet Med. 1994 Jul;11(6):528-33 - PubMed
  81. Diabetologia. 1993 Oct;36(10):883-92 - PubMed
  82. Diabetes Care. 1991 Nov;14(11):1001-5 - PubMed
  83. Monatsschr Kinderheilkd. 1984 Sep;132(9):635-9 - PubMed
  84. Diabet Med. 1991 May;8(4):338-45 - PubMed
  85. N Engl J Med. 1986 Jul 24;315(4):224-30 - PubMed
  86. Pediatr Clin North Am. 1987 Aug;34(4):919-34 - PubMed
  87. Diabetologia. 1992 Sep;35(9):880-3 - PubMed
  88. Diabetes Care. 1979 Jul-Aug;2(4):342-8 - PubMed
  89. Diabetes Care. 1991 Jul;14(7):593-6 - PubMed
  90. J Occup Med. 1975 Nov;17(11):716-21 - PubMed
  91. Ann Intern Med. 1992 Apr 15;116(8):660-71 - PubMed
  92. BMJ. 1991 Sep 14;303(6803):617-21 - PubMed
  93. Diabetes Care. 1991 Nov;14(11):982-8 - PubMed
  94. BMJ. 1993 Jan 16;306(6871):187-9 - PubMed
  95. Diabetes. 1984 Mar;33(3):271-6 - PubMed
  96. Lancet. 1993 May 22;341(8856):1306-9 - PubMed

MeSH terms

Publication Types

LinkOut - more resources